There are 3 major types of MGUS. Each has a progression phenotype that’s different. 11/

Presenting outcomes of Largest cohort of Allogenic transplant in CML blast crisis from India. 🔑 Takeaway 1. Post transplant maintenance is very important to prevent relapses. 2. Prefer Ponatinib as TKI. Outcomes are gradually improving over time with better supportive care.

DiNardo: Clad+Ven+LDAC or Flu potential solution for monocytic/RAS mutant Ven resistant AML clones? #ASH24 ASH

That’s super CLEVER approach to treat refractory MDS/AML Let’s release brakes on Macrophages #ASCO25

🧬✨ ATRA Goes Beyond APL! 🔬💊 All-trans retinoic acid (ATRA), the vitamin A derivative that cured APL by reactivating differentiation in leukemic blasts, is now stepping into non-APL AML 🧠🔥 🧱 In a new twist, ATRA doesn’t target blasts directly—but instead acts on the bone

Very imp study esp for countries like India where infection related mortality during HIDAC is high

Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial - The Lancet Haematology thelancet.com/journals/lanha… 1. CR/CRi rate 77% in RR B-cell ALL

Excellent summary of #ICML2025 for R/R DLBCL ‘Three regimens. Three new paths forward. All better than what rituximab plus GemOx could offer’ POLARGO- STARGLO-SUNMO and then the newer DLBCL Classifiers LymphoMAP particularly of interest in the context of CAR-T efficacy

आपण स्वतः दिवसभर "please do the needful" आणि "I will revert back" चे इमेल पाठवतो हे विसरून विमानातील फ्युएल कंट्रोल स्विच कसा वापरायचा यावर मत ठणकावता आले पाहिजे.

The Man Who Never Got a Nobel, But Gave the World Methotrexate — A story of forgotten genius, cancer, arthritis, psoriasis… and hope. 💊💔🧬

Handy for BMT physicians considering BMT for older kids with Thalassemia Liver damage is common due to Iron overload in Thalassemia

➡️ Check out our manuscript, just published in ACS Journal Cancer describing the "Contemporary outcomes of octa‐nonagenarians with ND-AML,👴🏼 " possibly the largest analysis in this high-risk but commonly encountered age group in AML ✅ acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… MD Anderson Cancer Center #leusm

We are all witnessing it here on X and in reality. Conscientiousness in free fall, neuroticism increasing.

Govt 🏥 residency: Volume> quality. See everything, do everything, learn to survive Pvt 🏥: Quality⬆️ bt volm⏬ Perfect the craft, but see ⬇️variety You need both to become a complete 👨🏻‍⚕️, but the tenacity, resilience and decisiveness that govt teaches, no pvt can match! #neetpg25

Maybe THE debate in transplant at the moment⁉️ Does HLA matter in the PTCY era? Join COSTEM Congress from September 25–28 for this exciting controversy! Register here: bit.ly/4a1Pzn7 For the full program: bit.ly/3P3dJW8 DM if you need support...

Nothing is working in India. Never been this pessimistic about my beloved country. For the average citizen, it feels like a slow collapse wrapped in noise and selfies. 1.City life is punishment Potholes. Garbage. Waterlogging. No planning. No shame. 2.Courts

Hospital ranking by Revenue /Doctor 🤯 Does this surprise you? Sundar Sankaran I just started reading the book you recommended a couple of days back sir 😊

CONGRESS | #SOHO2025 | PRESENTATION Nicholas Short MD MD Anderson Cancer Center discusses the impact of TP53 abnormalities on outcomes in ALL, and considerations for optimal treatment. Data have demonstrated that the prognostic impact of TP53 mutations is dependent on age and VAF (VAF ≥45%